Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

The Outcomes of Ponatinib Therapy in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program

Tomasz Sacha,Elzbieta Szczepanek,Paulina Dumnicka,Joanna Gora-Tybor,Joanna Niesiobedzka-Krezel,Witold Prejzner,Ewa Wasilewska,Janusz Kloczko,Hanna Ciepluch,Wioletta Makowska,Elzbieta Patkowska,Joanna Wasilewska,Grazyna Bober,Malgorzata Kopera,Ryszard Wichary,Renata Kroll-Balcerzak,Tomasz Gromek,Malgorzata Wach,Anna Rudkowska-Kazanowska,Magdalena Swiniarska,Edyta Paczkowska,Monika Biernat,Monika Joks,Marta Oller,Renata Kasza,Aleksandra Kostyra,Justyna Gil,Olga Grzybowska-Izydorczyk

Clinical Lymphoma Myeloma & Leukemia（2021）

Cited 4|Views42
Key words
Third generation TKI,real-life data,efficacy and safety,resistance,intolerance,CML
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined